Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Mouwasat Medical Services CoSAU:4002 +0.25%100 Median PS Value is ﷼99.56 as of Jul. 18, 2026, which is 100% below its 10-year median of 1.33. GuruFocus rates SAU:4002 with a GF Score™ of 100/100 and a GF Value™ of ﷼109.50 (Significantly Undervalued). The stock has 5 warning signs investors should review. Among 262 Healthcare Providers & Services companies, Mouwasat Medical Services Co ranks better than 59.92% on this metric.
This valuation method assumes that the stock valuation will revert to its historical (10-Year) median in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.
The historical rank and industry rank for Mouwasat Medical Services Co's Median PS Value or its related term are showing as below:
SAU:4002'
s Price-to-Median-PS-Value Range Over the Past 10 Years
Min: 0.61 Med: 1.33 Max: 1.65
Current: 0.61
During the past 13 years, the highest Price to Median PS Value of Mouwasat Medical Services Co was 1.65. The lowest was 0.61. And the median was 1.33.
SAU:4002's Price-to-Median-PS-Value is ranked better than 59.92% of 262
companies
in the Healthcare Providers & Services industry
Industry Median: 0.71
vs SAU:4002: 0.61
Mouwasat Medical Services Co (SAU:4002) Median PS Value Explanation
This valuation method assumes that the stock valuation will revert to its historical (10-Year) mean in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio
is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.
It also assumes that over time the profit margin is constant. If a company increases its profit margin to a sustainable level, this value might under-estimate its value. If it has permanent declined profit margins, this may over-estimate the company's value.
Mouwasat Medical Services Co's Price to Median PS Value for today is calculated as
Price to Median PS Value
=
Share Price
/
Median PS Value
=
60.90
/
99.56
=
0.61
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Mouwasat Medical Services Co Median PS Value Related Terms
Mouwasat Medical Services Co Median PS Value Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Mouwasat Medical Services Co Median PS Value Chart
SAU:4002 vs HCA, THC, DVA: Median PS Value Comparison
For the Medical Care Facilities subindustry, Mouwasat Medical Services Co's Price-to-Median-PS-Value, along with its competitors' market caps and Price-to-Median-PS-Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Mouwasat Medical Services Co Price-to-Median-PS-Value vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Mouwasat Medical Services Co's Price-to-Median-PS-Value distribution charts can be found below:
* The bar in red indicates where Mouwasat Medical Services Co's Price-to-Median-PS-Value falls into.
10-Year Median PS Ratio is 6.056.
Mouwasat Medical Services Co's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ﷼16.44.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Mouwasat Medical Services Co (SAU:4002) has a Median PS Value of ﷼99.56 as of Jul. 18, 2026. Median price-sales value is the stock value based on a company's 10-year median price-sales ratio, View historical data on Mouwasat Medical Services Co and its competitors. This is 7386% above median its historical median of 1.33. Over the past decade, Mouwasat Medical Services Co's Median PS Value has ranged from 0.61 to 1.65. According to the industry distribution chart, Mouwasat Medical Services Co ranks #105 out of 262 companies in the Healthcare Providers & Services industry, placing it in the top 40.1%.
Is Mouwasat Medical Services Co's Median PS Value too high?
Mouwasat Medical Services Co's current Median PS Value of ﷼99.56 is 7386% above median its 10-year median of 1.33. Over the past 10 years, this metric has ranged from a low of 0.61 to a high of 1.65. Based on the distribution chart, Mouwasat Medical Services Co ranks #105 out of 262 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Mouwasat Medical Services Co has a GF Score™ of 100/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Mouwasat Medical Services Co's Median PS Value compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Mouwasat Medical Services Co ranks #105 out of 262 companies for Median PS Value. This puts Mouwasat Medical Services Co in the upper half of its industry. The industry median Median PS Value is 0.71. Historically, Mouwasat Medical Services Co's own Median PS Value has ranged from 0.61 to 1.65 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Median PS Value for a Healthcare Providers & Services company?
The median Median PS Value among Healthcare Providers & Services companies is 0.71, based on 262 companies in the industry. Companies in the top quartile (top 25%) have a Median PS Value significantly above this median, while those in the bottom quartile fall well below. However, Median PS Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Median PS Value mean?
A high Median PS Value can signal that a stock is expensive relative to its fundamentals. Median price-sales value is the stock value based on a company's 10-year median price-sales ratio, View historical data on Mouwasat Medical Services Co and its competitors. For the Healthcare Providers & Services industry, the median Median PS Value is 0.71 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Mouwasat Medical Services Co's current Median PS Value is ﷼99.56, which is 7386% above median its own 10-year median of 1.33. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Mouwasat Medical Services Co stock overvalued right now?
Based on GuruFocus' analysis, Mouwasat Medical Services Co (SAU:4002) is currently considered Significantly Undervalued. The stock's GF Value™ is ﷼109.50, compared to a current price of ﷼60.90 — trading 44.4% below its estimated fair value. The current Median PS Value is ﷼99.56, which is 7386% above median its 10-year median of 1.33. Mouwasat Medical Services Co's overall GF Score™ is 100/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Median PS Value calculated?
Median PS Value is calculated from a company's financial statements. For Mouwasat Medical Services Co (SAU:4002), the current Median PS Value is ﷼99.56 as of Jul. 18, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Mouwasat Medical Services Co (SAU:4002) Overvalued in 2026?
Based on GuruFocus' analysis, Mouwasat Medical Services Co stock appears to be undervalued.
The current stock price of ﷼60.90 is trading 44.4% below its estimated GF Value™ of ﷼109.50.
GuruFocus considers Mouwasat Medical Services Co to be Significantly Undervalued.
Key valuation signals for SAU:4002:
Median PS Value: ﷼99.56 (7386% above median its 10-year median of 1.33)
GF Value™: ﷼109.50 vs. price of ﷼60.90 (44.4% below fair value)
No single metric tells the full story. See the SAU:4002 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Mouwasat Medical Services Co is engaged in the acquisition, management, operation, and maintenance of hospitals, medical centers, drug stores, pharmacies, and wholesale of medical equipment and drugs. The company also operates skin care centers that offer clinical and cosmetic dermatology, aesthetic and reconstructive plastic surgery, weight reduction, and esthetician services. It operates in two segments Medical Services segment and Pharmaceuticals out of which the Medical Services segment derives the majority of revenue. The Medical Services segment includes Inpatient and outpatient services. The company provides specialized centers: Eye Center, Robotic Surgeries Center, Diabetes Center, Fertility Unit, Cardiology Center, Stroke Unit, Long Term Care Center, Obesity Center, and others.
100GF Score
Get the complete analysis for SAU:4002
Median PS Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SAU:4002 has been successfully added to your 
